Expand EBS Menu
EBS MENU

EBS Latest Press Releases

-- December 12, 2025 --

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site Globe Newswire 8:30 AM

-- November 18, 2025 --

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access Globe Newswire 8:00 AM

-- November 12, 2025 --

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors Globe Newswire 4:01 PM

-- October 29, 2025 --

Emergent BioSolutions Reports Third Quarter 2025 Financial Results Globe Newswire 4:15 PM

-- October 28, 2025 --

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness Globe Newswire 8:00 AM

-- October 8, 2025 --

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025 Globe Newswire 7:45 AM

-- September 24, 2025 --

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone Globe Newswire 4:05 PM

-- September 19, 2025 --

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner Globe Newswire 8:34 AM

-- September 15, 2025 --

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain Globe Newswire 8:35 AM

-- September 9, 2025 --

Emergent BioSolutions Receives New Contract Modification for ACAM2000, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness Globe Newswire 7:30 AM

-- September 2, 2025 --

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use Globe Newswire 7:40 AM

-- August 29, 2025 --

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day Globe Newswire 8:05 AM

-- August 27, 2025 --

Emergent BioSolutions to Participate in Upcoming Investor Conferences Globe Newswire 8:01 AM

-- August 21, 2025 --

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day Globe Newswire 8:45 AM

-- August 6, 2025 --

Emergent BioSolutions Reports Second Quarter 2025 Financial Results Globe Newswire 4:15 PM

-- July 28, 2025 --

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox Globe Newswire 8:50 AM
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives Globe Newswire 8:50 AM
Market Data Delayed 15 Minutes